Biosphere tenant Iksuda Therapeutics raises $47m to reinforce Antibody Drug Conjugate pipeline

UK – UK-headquartered Iksuda Therapeutics has announced the closing of a $47m (£34m) financing round, with the funds to be used to support the advancement of its lead antibody drug conjugate (ADC) assets. This includes the company’s lead pre-clinical ADC candidate IKS03, a potentially ‘best-in-class’ CD19-targeted asset for B-cell cancers. Iksuda will use the funds to support the progression of IKS03 into first-in-human Phase clinical trials, and will also be used to fast-track its earlier-stage programs. Currently, the company’s drug development pipeline is focused on the improved safety and efficacy…

Read More

Uganda tightens belt around COVID-19 containment measures by imposing strict lockdown

UGANDA – Uganda’s President Yoweri Museveni has re-imposed a strict lockdown that includes closure of schools and suspension of inter-district travel to help tone down a surge in COVID-19 cases in the East African country. The new measures include the closure of all educational institutions, partial bans on travel, shutdown of weekly open markets, and suspension of church services. These restrictions will be imposed for 42 days, after which government will asses their impact and determine whether to extend or halt them. At the beginning of the pandemic, Uganda implemented…

Read More

Lupin launches digital asthma educator platform in India

INDIA – Drug major Lupin has announced the launch of its digital asthma educator platform to guide patients on the correct technique of using inhalers. The new platform is the latest initiative under Lupin’s long-running umbrella program, “Joint Airways Initiative” (JAI), for patients suffering from respiratory ailments. Lupin said, according to estimates, India has nearly 35 million people living with asthma, including children. While there is no cure for asthma, it is manageable with proper treatment, vigilance, drug adherence, and regular medical checks, thus enabling patients to lead a normal…

Read More

African Union COVID-19 Pass among the new requirements for transit in Ethiopia’s new travel advisory

ETHIOPIA – The continued surge of Covid-19 infections in some parts of the world has led to revised travel advisory by the government of Ethiopia. An African Union COVID-19 Pass will now be required as one enters or exits the country. Health screening at the borders has also been scaled up to secure long-term biosecurity. The country has witnessed a steady rise in Covid infections per day. Currently, Ethiopia is in the lead with over 270 thousand Covid cases in the Eastern Africa Region. So far, the country has recorded…

Read More

Penda health set to plough USD 1.06 million into its expansion scheme

KENYA – Penda Health, a private medical services provider in Kenya, has announced its plans to invest about Sh115 million (USD 1.06 million) in expansion to run until next year. Founded in 2012, Penda Health operates a chain of medical centers in Nairobi, Kenya that offer high-quality, affordable healthcare services patients can trust.  The health purposes to add three branches this year and five more next year on the Coast, eastern, central and Rift Valley regions of the country through an investment by venture capitalists and partners. The care service…

Read More

Africa’s confirmed COVID-19 cases surpass 4.92 million

AFIRCA – The number of confirmed COVID-19 cases in Africa reached 4,925,978 as of Monday morning, the Africa Centers for Disease Control and Prevention (Africa CDC) said. The Africa CDC, the specialized healthcare agency of the African Union, said the death toll from the pandemic stands at 132,425 while 4,445,872 patients across the continent have recovered from the disease. South Africa, Morocco, Tunisia, Ethiopia and Egypt are the countries with the most cases in the continent, according to the Africa CDC. South Africa has recorded the highest COVID-19 cases in…

Read More

Dr Reddy’s recalls 2,980 bottles of cholesterol lowering drug in US

INDIA – Drug major Dr Reddy’s Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues. Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age. The drug is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes, and other risk factors such as eye problems, kidney diseases, or high blood pressure. As per the US Food and Drug Administration’s latest Enforcement report, the Hyderabad-based drug major is…

Read More